In a symposium beginning Friday at 3:45 p.m. PT in Ballroom 20A-C of the convention center, investigators including W. Timothy Garvey, MD, will present results from the SURMOUNT 2 trial of tirzepatide. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
Coming up: SURMOUNT 2 Trial Results and Potential Role of Tirzepatide in Treating Obesity in Type 2 Diabetes
